# OnCo record dfp-10917 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/dfp-10917/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "dfp-10917" ;
  schema:name "DFP-10917"@en ;
  schema:description "DFP-10917 is an experimental nucleoside analogue from Delta-Fly Pharma, in phase 3 trials for relapsed or refractory acute myeloid leukaemia; its current status is not stated."@en ;
  schema:url <https://onco.cc/drugs/dfp-10917/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.delta-flypharma.co.jp/en/r-and-d>, <https://clinicaltrials.gov/study/NCT03926624>, <https://clinicaltrials.gov/study/NCT06382168>, <https://clinicaltrials.gov/search?intr=DFP-10917> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Nucleoside analogue (continuous intravenous infusion)" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:companies <https://onco.cc/companies/delta-fly-pharma/> ;
  onco:trials <https://onco.cc/trials/nct03926624/>, <https://onco.cc/trials/nct06382168/>, <https://onco.cc/trials/nct01702155/> .